-
Signature
-
/s/ Danika Haueisen, Attorney-in-Fact for Katherine Lee Clifford
-
Issuer symbol
-
ACN
-
Transactions as of
-
26 Jan 2026
-
Net transactions value
-
-$220,985
-
Form type
-
4
-
Filing time
-
27 Jan 2026, 19:49:34 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Clifford Katherine Lee |
Chief Leadership & HR Officer |
C/O ACCENTURE, 500 W. MADISON STREET, CHICAGO |
/s/ Danika Haueisen, Attorney-in-Fact for Katherine Lee Clifford |
27 Jan 2026 |
0002080407 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$19,640 |
-71 |
-1% |
$276.62 |
6,717 |
26 Jan 2026 |
Direct |
F1 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$8,904 |
-32 |
-0.48% |
$278.24 |
6,685 |
26 Jan 2026 |
Direct |
F1, F2 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$47,040 |
-168 |
-2.5% |
$280.00 |
6,517 |
26 Jan 2026 |
Direct |
F1, F3 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$144,835 |
-514 |
-7.9% |
$281.78 |
6,003 |
26 Jan 2026 |
Direct |
F1, F4 |
| transaction |
ACN |
Class A ordinary shares |
Sale |
$566 |
-2 |
-0.03% |
$283.25 |
6,001 |
26 Jan 2026 |
Direct |
F1 |
| holding |
ACN |
Class A ordinary shares |
|
|
|
|
|
27 |
26 Jan 2026 |
Held by an Immediate Family Member |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: